Before trying weight-loss aids marketed as miracle solutions, consult your doctor, who can help create a plan based on science and your personal goals
The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
His lawsuit alleges that Ozempic caused the DVT and other injuries
In 2024, the FDA said that GLP-1 drugs were no longer in a shortage, which was expected to put an end to the compounding
The FDA has a tool that can help you determine how many you need based on age, gender, and activity level
Or instructions from your doctor